Business Context and Reporting Period
This Form 8-K Current Report was filed by Bristol-Myers Squibb Company on December 4, 2007. The report discloses a corporate governance event regarding the election of a new director to the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Board Expansion: The size of the Board of Directors was increased to ten members.
- New Director Election: Alan J. Lacy was elected to the Board of Directors, effective January 2, 2008.
- Committee Assignment: Mr. Lacy was appointed to serve as a member of the Audit Committee.
- Independence: The Board determined Mr. Lacy is independent under NYSE Listing Standards and the Company's independence standards.
Guidance, Outlook, and Management Commentary
The filing contains no financial guidance, outlook, or management commentary regarding business operations. It notes that Mr. Lacy will stand for election by stockholders at the Annual Meeting in May 2008. There are no related party transactions between the Company and Mr. Lacy.
Compensatory Arrangements
Mr. Lacy will receive compensation in accordance with the standard arrangement for non-employee directors:
- Annual retainer: $55,000
- Per meeting fee: $2,000
- Annual award: 3,500 deferred share units under the 1987 Deferred Compensation Plan for Non-Employee Directors
Investor Verification Checklist
- Verify the effective date of Alan J. Lacy's board membership (January 2, 2008).
- Confirm the total size of the Board of Directors is now ten members.
- Review the attached press release (Exhibit 99.1) for additional biographical details on Mr. Lacy.
- Note that Mr. Lacy serves as a senior advisor to Oak Hill Capital Partners, L.P.